CNNMoney.com
Companies Economy International Corrections Pre-market Trading After-hours Trading Winners/Losers/Actives Bonds Currencies Commodities World Markets Money Magazine Real Estate Taxes Jobs Ask the Expert Money 101 Autos Mutual Funds The Help Desk Loan Center Best Places to Live Ask the Expert Ultimate Guide to Retirement Retirement Calculators Best Funds Ask the Mole Best Places to Retire Big Tech Blog Techland Blog Sectors and Stocks Fortune 500 Techs Tech Talk 100 Best Places to Launch Ultimate Resource Guide Small Biz Makeovers FSB 100 Ask & Answer Fortune 500 Technology Investing Management C-Suite Rankings Main Create Portfolio Edit Portfolio Create Alerts Edit Alerts

No cold medicine for kids under 2: FDA

Agency warns of 'potentially life threatening side effects,' but sales impact on drugmakers is seen as limited.

Subscribe to Companies
google my aol my msn my yahoo! netvibes
Paste this link into your favorite RSS desktop reader
See all CNNMoney.com RSS FEEDS (close)
By Aaron Smith, CNNMoney.com

NEW YORK (CNNMoney.com) -- The U.S. Food and Drug Administration warned parents Thursday not to give over-the-counter cold medicine to children under age 2 because of "serious and potentially life-threatening side effects."

"The reality is these products are used quite a bit in this age group, and parents are using them without getting advice from a healthcare provider," said Dr. Charles Ganley, director of the FDA's Office of Nonprescription Drugs, in a teleconference with reporters.

Dr. Lisa Mathis, a new drug specialist in the FDA's Pediatric and Maternal Health Staff, said side effects could include convulsions, rapid heart rates, reduced consciousness or death.

The warning affects drugmakers Johnson & Johnson (JNJ, Fortune 500), Wyeth (WYE, Fortune 500) and Novartis (NVS) - but not by much, as over-the-counter medicine makes up just a sliver or those companies' sales.

For example, over-the-counter drugs make up less than one-tenth of Wyeth sales, and cold medicine for babies and toddlers make up a smaller fraction of that revenue.

Also, the warning was expected, as the Food and Drug Administration has been investigating the use of cold medicine in young children for some time. In October, FDA advisers voted 13-9 that cold medicine shouldn't be used in children under age 6.

"It reaffirms our voluntary recall in October," said Wyeth spokesman Doug Petkus. "We felt this was a way to reduce dosing errors and overdosing in children, who we felt were the most vulnerable."

Novartis also issued a statement that it supports the FDA action.

Les Funtleyder, analyst for Miller Tabak, said the sales impact on drugmakers is "limited."

"Higher-value drugs and medical devices are more meaningful to sales than cold medicine," said Funtleyder. "I think the more important issue here is not business, but public health."

The FDA said it was continuing to investigate the safety and effectiveness of over-the-counter cold medicine in children between the ages of 2 and 11. To top of page

Photo Galleries
6-figure towns Holmdel, N.J., residents pull in more than $159,000 a year. Which other places in our Best Places database have high incomes? More
What a million buys at the sea shore The lure of salt water has always made ocean-front homes among the most expensive of residential real estate. Here's what a million bucks will get you sea side this summer. More
Brand name companies go bankrupt As consumers cut back, businesses are scrambling. 14 brands you know -- from an NHL hockey team to Obama's suit maker -- that are hitting the skids. More
© 2009 Cable News Network. A Time Warner Company. All Rights Reserved. Terms under which this service is provided to you. Privacy Policy
Copyright © 2009 BigCharts.com Inc. All rights reserved. Please see our Terms of Use.
MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc.
Intraday data provided by Interactive Data Real-Time Services and subject to the Terms of Use.
Intraday data is at least 20-minutes delayed. All times are ET.
Historical, current end-of-day data, and splits data provided by Interactive Data Pricing and Reference Data.
Fundamental data provided by Morningstar, Inc..
SEC Filings data provided by Edgar Online Inc..
Earnings data provided by FactSet CallStreet, LLC.